$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
研究支持某些非缓解ALL儿童和青少年使用HSCT
2025-10-19 11:44:20
Check Details
达沙替尼有什么注意事项?
2025-10-19 11:44:20
Check Details
达沙替尼片一盒的价格
2025-10-19 11:44:20
Check Details
达沙替尼2020价格
2025-10-19 11:44:20
Check Details
达沙替尼是否纳入医保?
2025-10-19 11:44:20
Check Details
达沙替尼进入医保了没?
2025-10-19 11:44:20
Check Details
达沙替尼是医保药吗?
2025-10-19 11:44:20
Check Details
达沙替尼是化疗药吗?
2025-10-19 11:44:20
Check Details
达沙替尼是否在医保报销范围内?
2025-10-19 11:44:20
Check Details
达沙替尼的价格是多少?
2025-10-19 11:44:20
Check Details
达沙替尼多少钱?
2025-10-19 11:44:20
Check Details
达沙替尼中国上市价格
2025-10-19 11:44:20
Check Details
1
2
...
441
442
443
444
445
446
447
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
3
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
4
A Key Therapeutic Breakthrough Against T315I-Mutant CML
5
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
6
Tafasitamab and Lenalidomide Combination Therapy Guide
7
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
8
Gilteritinib Professional Medication Guide & Dosage Management
9
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
10
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
11
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
12
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation